![Stephen Tulipano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Tulipano
Corporate Officer/Principal chez
The American Institute of Certified Public Accountants
Profil
Stephen J.
Tulipano is currently a Member at The American Institute of Certified Public Accountants and a Member at the Massachusetts Society of Certified Public Accountants, Inc. Previously, he worked as the Director-Corporate Accounting at Biogen, Inc. from 1998 to 2006.
He also served as the Manager-External Reporting at Digital Equipment Corp.
Additionally, he held the position of Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2014 to 2018 and Chief Financial Officer & Secretary at Javelin Pharmaceuticals, Inc. from 2009 to 2010.
Currently, he is the Chief Financial Officer at Stoke Therapeutics, Inc. from 2019 to 2024.
Mr. Tulipano obtained his undergraduate degree from Salem State University and his MBA from Sawyer Business School.
Postes actifs de Stephen Tulipano
| Sociétés | Poste | Début |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Massachusetts Society of Certified Public Accountants, Inc.
 Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for CPAs | Corporate Officer/Principal | - |
Anciens postes connus de Stephen Tulipano
| Sociétés | Poste | Fin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Directeur Financier/CFO | 07/05/2024 |
| ALDEYRA THERAPEUTICS, INC. | Directeur Financier/CFO | 31/07/2018 |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Directeur Financier/CFO | 01/07/2010 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 01/04/2006 |
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Corporate Officer/Principal | - |
Formation de Stephen Tulipano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Digital Equipment Corp.
Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Salem State University
 Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Massachusetts Society of Certified Public Accountants, Inc.
Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for CPAs | Commercial Services |
Sawyer Business School
 Sawyer Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
